PVD News

DIABETES NEWS JOURNAL

African-American people are at higher risk for diabetes and peripheral arterial disease (PAD), which combined make them more susceptible to preventable amputations. African-Americans are, statistically, twice as likely as non-Hispanic whites to have PAD. At the same time, one in four older African-American has diabetes.

JOURNAL OF THE AMERICAN HEART ASSOCIATION

Cardiovascular diseases (CVD), principally ischemic heart disease and stroke, are the leading cause of death in the United States. Although management of CVD has led to improved mortality over the years, striking disparities in outcomes have persisted and widened among racial and ethnic groups. These disparities segregate along the lines of race and ethnicity, socioeconomic status, and geography. Health disparities, as defined by the World Health Organization, are “systematic, socially produced (and therefore modifiable) and unfair” conditions that dis...

JOURNAL OF THE AMERICAN HEART ASSOCIATION

Background: Rates of major lower extremity amputation in patients with peripheral artery disease are higher in rural communities with markers of low socioeconomic status, but most Americans live in metropolitan areas. Whether amputation rates vary within US metropolitan areas is unclear, as are characteristics of high amputation rate urban communities.

CISION PR NEWSWIRE

XARELTO® is the only anticoagulant in 20 years to show significant benefit in patients with PAD who remain at high risk for major thrombotic events, including acute limb ischemia and amputation. PAD impacts 20 million Americans and is the leading cause of amputations in the U.S., with rates continuing to rise.

THE ROLLA DAILY NEWS

High levels of lipids (fats) in the blood, including cholesterol and triglycerides, is also called "hyperlipidemia."

Hyperlipidemia can lead to your blood vessels getting blocked with fatty deposits, limiting blood flow. This condition also increases your risk of developing cardiovascular disease, affecting blood vessels supplying the heart (coronary artery disease), brain (cerebrovascular disease) and arms and legs (peripheral artery disease).

JOURNAL OF BIOSCIENCE AND BIOENGINEERING

Abstract: Conventional treatments of peripheral vascular disease and coronary artery disease have partial success but are still limited. Methods to deliver angiogenic factors into ischemic areas using gene, protein and cell therapies are faced with difficult issues such a delivery, effective concentration and duration of action. Tissue engineering offers the possibility of creating a functional self-contained three-dimensional (3D) unit that works as a coordinated biological pump that can secrete a whole range of angiogenic factors. We report a tissue e...

VASCULAR

Introduction: The aim of this study was to evaluate the influence of pedal arch quality on 5-year survival and limb salvage in diabetic patients with foot wounds undergoing peripheral angiography.

VASCULAR

Background/objective: To evaluate the safety and utility of a new in Europe intravascular ultrasound (IVUS) catheter in a case of peripheral arterial disease caused by in-stent restenosis of the superficial femoral artery.

EClinicalMedicine

Background: Evidence shows important ethnic differences in vascular dysfunction rates; however, the mechanisms driving these differences remain unclear. One potential factor is the ethnic differences in the role of inflammation in vascular injury. We tested the hypothesis that low-grade inflammation is unequally associated with vascular dysfunction in different ethnic groups.

DOCWIRE NEWS

It is well established that patients with peripheral artery disease (PAD) as well abdominal aortic aneurysm (AAA) have an increased cardiovascular (CV) mortality. Despite this higher risk, PAD and AAA patients are often suboptimality treated. This study assessed the CV profile of PAD and AAA patients, quantifying the survival benefits of target-based risk-factors modification even in light of the COVID-19 pandemic.